Paper29312973
Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
Xie DY and 4 others. Hepatobiliary Surg Nutr, 2017. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. Papers, record 29312973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29312973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 29532810 | Hepatocellular carcinoma: one world, one cancer-different guidelines? | https://conductscience.org/library/papers/29532810 | PubMed |
| Comment in | 30221159 | Searching for common ground in a global disease. | https://conductscience.org/library/papers/30221159 | PubMed |
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25027973 | A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. | J Gastroenterol | 2015 | https://conductscience.org/library/papers/25027973 | PubMed |
| 2 | 27781197 | Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). | Liver Cancer | 2016 | https://conductscience.org/library/papers/27781197 | PubMed |
| 3 | 28752469 | 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. | Ann Surg Oncol | 2018 | https://conductscience.org/library/papers/28752469 | PubMed |
| 4 | 21374666 | Management of hepatocellular carcinoma: an update. | Hepatology | 2011 | https://conductscience.org/library/papers/21374666 | PubMed |
| 5 | 26280007 | JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. | Liver Cancer | 2014 | https://conductscience.org/library/papers/26280007 | PubMed |
| 6 | 20512990 | Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. | Hepatology | 2010 | https://conductscience.org/library/papers/20512990 | PubMed |
| 7 | 20175034 | Current strategy for staging and treatment: the BCLC update and future prospects. | Semin Liver Dis | 2010 | https://conductscience.org/library/papers/20175034 | PubMed |
| 8 | 25612807 | Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. | J Vasc Interv Radiol | 2015 | https://conductscience.org/library/papers/25612807 | PubMed |
| 9 | 17522506 | A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. | Ann Surg | 2007 | https://conductscience.org/library/papers/17522506 | PubMed |
| 10 | 19916210 | The international position on laparoscopic liver surgery: The Louisville Statement, 2008. | Ann Surg | 2009 | https://conductscience.org/library/papers/19916210 | PubMed |
| 11 | 28620797 | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. | Hepatol Int | 2017 | https://conductscience.org/library/papers/28620797 | PubMed |
| 12 | 26079914 | Safety of ALPPS Procedure by the Anterior Approach for Hepatocellular Carcinoma. | Ann Surg | 2016 | https://conductscience.org/library/papers/26079914 | PubMed |
| 13 | 21829027 | Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. | Dig Dis | 2011 | https://conductscience.org/library/papers/21829027 | PubMed |
| 14 | 25981135 | Downstaging hepatocellular carcinoma: A systematic review and pooled analysis. | Liver Transpl | 2015 | https://conductscience.org/library/papers/25981135 | PubMed |
| 15 | 11391528 | Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. | Hepatology | 2001 | https://conductscience.org/library/papers/11391528 | PubMed |
| 16 | 24886354 | Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis. | BMC Gastroenterol | 2014 | https://conductscience.org/library/papers/24886354 | PubMed |
| 17 | 25773941 | Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? | Eur Radiol | 2015 | https://conductscience.org/library/papers/25773941 | PubMed |
| 18 | 26765068 | Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. | Hepatology | 2016 | https://conductscience.org/library/papers/26765068 | PubMed |
| 19 | 25379854 | Early survival and safety of ALPPS: first report of the International ALPPS Registry. | Ann Surg | 2014 | https://conductscience.org/library/papers/25379854 | PubMed |
| 20 | 28485409 | Immunotherapy: Nivolumab keeps HCC in check and opens avenues for checkmate. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28485409 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42170426 | Significance of surgical margin width versus anatomical resection for hepatocellular carcinoma. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42170426 | PubMed |
| 40547955 | Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma. | Liver Cancer | 2025 | https://conductscience.org/library/papers/40547955 | PubMed |
| 40060905 | Serum-biomarker-based population screening model for hepatocellular carcinoma. | iScience | 2025 | https://conductscience.org/library/papers/40060905 | PubMed |
| 39759152 | Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound. | Front Oncol | 2024 | https://conductscience.org/library/papers/39759152 | PubMed |
| 39399114 | Development of prognostic models for advanced multiple hepatocellular carcinoma based on Cox regression, deep learning and machine learning algorithms. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39399114 | PubMed |
| 38797901 | Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38797901 | PubMed |
| 38438972 | Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/38438972 | PubMed |
| 37041364 | Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm. | Langenbecks Arch Surg | 2023 | https://conductscience.org/library/papers/37041364 | PubMed |
| 36619232 | LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/36619232 | PubMed |
| 36246809 | Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells. | World J Clin Cases | 2022 | https://conductscience.org/library/papers/36246809 | PubMed |
| 34824186 | Role of Tumor Biomarkers in the Surveillance of Hepatocellular Carcinoma. | Korean J Gastroenterol | 2021 | https://conductscience.org/library/papers/34824186 | PubMed |
| 34777698 | miR-4454 Promotes Hepatic Carcinoma Progression by Targeting Vps4A and Rab27A. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34777698 | PubMed |
| 34773467 | Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI? | Abdom Radiol (NY) | 2022 | https://conductscience.org/library/papers/34773467 | PubMed |
| 34715816 | Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34715816 | PubMed |
| 33860031 | Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33860031 | PubMed |
| 33330822 | Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines. | Glob Health Med | 2020 | https://conductscience.org/library/papers/33330822 | PubMed |
| 33297335 | Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives. | Biomedicines | 2020 | https://conductscience.org/library/papers/33297335 | PubMed |
| 33097694 | Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/33097694 | PubMed |
| 32884985 | Advances in the early diagnosis of hepatocellular carcinoma. | Genes Dis | 2020 | https://conductscience.org/library/papers/32884985 | PubMed |
| 32646378 | The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia. | BMC Gastroenterol | 2020 | https://conductscience.org/library/papers/32646378 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29312973
GET https://conductscience.org/api/papers/v1/29312973/references?page=2